Bioequivalence Study Between VHX-896 Tablets and Iloperidone Tablets in Healthy Volunteers
Clinical trial NCT04969211 · COMPLETED
Trial details
- NCT number
- NCT04969211
- Sponsor
- Vanda Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-30
- Primary completion
- 2021-10-13
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.